SCA
LABU icon

Sassicaia Capital Advisers’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Sassicaia Capital Advisers’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,660
Closed -$235K – 42
2022
Q4 		$235K Buy
+1,660
New +$232K 0.58% 24
2021
Q2 		– Sell
-325
Closed -$513K – 53
2021
Q1 		$513K Buy
+325
New +$761K 0.29% 34

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIP
Ahrens Investment Partners Lafayette, Louisiana $202M AUM 3.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Sassicaia Capital Advisers's LABU Position: Q1 2023 in Review

Sassicaia Capital Advisers sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2023, closing a stake of 1,660 shares — an estimated $235K sold.

Sassicaia Capital Advisers first reported a position in LABU in Q1 2021 and held it in 2 quarters. The position peaked at $513K in Q1 2021. 57 funds tracked by Wall St. Rank hold LABU as of Q1 2023.

  • Sassicaia Capital Advisers reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2023 after selling out during the quarter.
  • Sassicaia Capital Advisers sold 1,660 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2023, an estimated $235K.
  • Sassicaia Capital Advisers first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2021 and held it in 2 quarters.
  • Sassicaia Capital Advisers's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $513K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2023.

Based on Sassicaia Capital Advisers's 13F filing for Q1 2023, filed 15 May 2023.